Genomic Health up on ASCO guidelines

GHDX was up $3.28 (16%) to $23.89 on Tuesday after the American Society of Clinical Oncology (ASCO) recommended use of Oncotype DX in its updated clinical practice guideline. The diagnostic assay anal...